SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Lighthouse who wrote (1349)2/16/2000 3:38:00 PM
From: nigel bates  Respond to of 3202
 
We're in relative valuation land now. Check out CRA HGSI CRGN HYSQ etc, and INCY doesn't look that expensive after all. Look at the market cap compared to what it was a few months back, and it does. Take your pick.

nig



To: Lighthouse who wrote (1349)2/16/2000 3:59:00 PM
From: Steven Rachbach  Read Replies (1) | Respond to of 3202
 
<<Can someone walk me through the valuation morass?>>

Not really, Lighthouse; it's more like pulling it out of my ass. All of the genomic leaders have sky high stock prices.. Whose genes will become blockbuster drugs? Who knows? You are just betting on a story right now -- that INCY, CRA, HGSI, etc. are the drug companies of the future.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News